875 related articles for article (PubMed ID: 19744518)
1. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
[TBL] [Abstract][Full Text] [Related]
2. Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty.
Durairajan SS; Yuan Q; Xie L; Chan WS; Kum WF; Koo I; Liu C; Song Y; Huang JD; Klein WL; Li M
Neurochem Int; 2008; 52(4-5):741-50. PubMed ID: 17964692
[TBL] [Abstract][Full Text] [Related]
3. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
[TBL] [Abstract][Full Text] [Related]
4. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures.
Thapa A; Woo ER; Chi EY; Sharoar MG; Jin HG; Shin SY; Park IS
Biochemistry; 2011 Apr; 50(13):2445-55. PubMed ID: 21322641
[TBL] [Abstract][Full Text] [Related]
5. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.
De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE
J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438
[TBL] [Abstract][Full Text] [Related]
6. Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.
Romeo M; Stravalaci M; Beeg M; Rossi A; Fiordaliso F; Corbelli A; Salmona M; Gobbi M; Cagnotto A; Diomede L
J Alzheimers Dis; 2017; 57(3):857-871. PubMed ID: 28282805
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of crocin on the amyloid fibril formation of Aβ42 peptide in vitro.
Ghahghaei A; Bathaie SZ; Kheirkhah H; Bahraminejad E
Cell Mol Biol Lett; 2013 Sep; 18(3):328-39. PubMed ID: 23737042
[TBL] [Abstract][Full Text] [Related]
8. Tabersonine inhibits amyloid fibril formation and cytotoxicity of Aβ(1-42).
Kai T; Zhang L; Wang X; Jing A; Zhao B; Yu X; Zheng J; Zhou F
ACS Chem Neurosci; 2015 Jun; 6(6):879-88. PubMed ID: 25874995
[TBL] [Abstract][Full Text] [Related]
9. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
[TBL] [Abstract][Full Text] [Related]
11. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
[TBL] [Abstract][Full Text] [Related]
12. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.
Sharoar MG; Thapa A; Shahnawaz M; Ramasamy VS; Woo ER; Shin SY; Park IS
J Biomed Sci; 2012 Dec; 19(1):104. PubMed ID: 23259691
[TBL] [Abstract][Full Text] [Related]
13. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
14. Ca(2+), within the physiological concentrations, selectively accelerates Abeta42 fibril formation and not Abeta40 in vitro.
Ahmad A; Muzaffar M; Ingram VM
Biochim Biophys Acta; 2009 Oct; 1794(10):1537-48. PubMed ID: 19595795
[TBL] [Abstract][Full Text] [Related]
15. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
[TBL] [Abstract][Full Text] [Related]
16. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
[TBL] [Abstract][Full Text] [Related]
17. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
Singh PK; Maji SK
Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
[TBL] [Abstract][Full Text] [Related]
19. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.
Hao J; Zhang W; Zhang P; Liu R; Liu L; Lei G; Su C; Miao J; Li Z
Neuropeptides; 2010 Aug; 44(4):305-13. PubMed ID: 20363024
[TBL] [Abstract][Full Text] [Related]
20. Critical role of interfaces and agitation on the nucleation of Abeta amyloid fibrils at low concentrations of Abeta monomers.
Morinaga A; Hasegawa K; Nomura R; Ookoshi T; Ozawa D; Goto Y; Yamada M; Naiki H
Biochim Biophys Acta; 2010 Apr; 1804(4):986-95. PubMed ID: 20100601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
